SCHEMBL30178466

SCHEMBL30178466

COc1ccc(N)c(C(C)CNC2CCN(C(=O)OC(C)(C)C)CC2)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.54
STS P08842 2/20 0.50
EPHX2 P34913 1/20 0.49
HTT P42858 2/20 0.46
NPC1 O15118 1/20 0.46
MAPT P10636 1/20 0.46
MAPK1 P28482 1/20 0.46
RAB9A P51151 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
MMP1 P03956 3/20 0.44
MMP3 P08254 3/20 0.44
MMP7 P09237 3/20 0.44
MMP9 P14780 3/20 0.44
MMP8 P22894 3/20 0.44
MMP13 P45452 3/20 0.44
MMP2 P08253 2/20 0.44
BACE1 P56817 2/20 0.44
DYRK1A Q13627 1/20 0.44
CTSD P07339 1/20 0.44
CTSE P14091 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17870704 0.87 MAPT (0.39) ALDH1A1EPHX2MAPTLMNA
SCHEMBL30178359 0.85 ALDH1A1 (0.51) ALDH1A1STSEPHX2HTTNPC1
SCHEMBL19873976 0.82 ACHE (0.39) ALDH1A1HTTMAPTMAPK1MEN1
SCHEMBL30178331 0.80 ALDH1A1 (0.56) ALDH1A1STSEPHX2HTTNPC1
SCHEMBL22587904 0.79 ALDH1A1 (0.68) ALDH1A1STSEPHX2HTTNPC1
SCHEMBL16136067 0.77 ALDH1A1 (0.68) ALDH1A1STSEPHX2HTTNPC1
SCHEMBL7381166 0.75 ALDH1A1 (0.69) ALDH1A1STSEPHX2HTTMAPT
SCHEMBL4732973 0.75 EPHX2 (0.61) ALDH1A1STSEPHX2HTTMAPT
SCHEMBL3267551 0.75 EPHX1 (0.57) ALDH1A1EPHX2HTTNPC1MAPT
SCHEMBL31191746 0.75 SLC2A1 (0.52) ALDH1A1STSEPHX2DYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3708566-B1 NOVEL HETEROCYCLIC COMPOUNDS AND THE USE THEREOF IN MEDICINE AND IN COSMETICS GALDERMA RES & DEV (FR) 2023-02-08 EP disclosed